Anti-Amyloid Beta Antibody (Donanemab)
Catalog No.
F1533
Anti-Amyloid Beta Antibody (Donanemab)
Featured Products
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeting the N-terminal pyroglutamate epitope of amyloid β (Aβ). Donanemab has the potential to be used in early Alzheimer's disease research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.36 kDa
Dry ice
1931944-80-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LY3002813-SC, LY3002813-IV
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05067
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Amyloid Beta
Please avoid freeze-thaw cycles.